Long-term outcome and intervention of urea cycle disorders in Japan

Journal of Inherited Metabolic Disease

Volumn 35, Issue 5, 2012, Pages 777-785

  Kido, Jun ^a   Nakamura, Kimitoshi ^a   Mitsubuchi, Hiroshi ^a   Ohura, Toshihiro ^b   Takayanagi, Masaki ^c   Matsuo, Masafumi ^d   Yoshino, Makoto ^e   Shigematsu, Yosuke ^f   Yorifuji, Tohru ^g   Kasahara, Mureo ^h   Horikawa, Reiko ^h   Endo, Fumio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SENDAI CITY HOSPITAL   (Japan)

^c CHIBA CHILDREN'S HOSPITAL   (Japan)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF FUKUI   (Japan)

^g OSAKA CITY GENERAL HOSPITAL   (Japan)

^h NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ARGININE; BENZOIC ACID; CITRULLINE;

ADOLESCENT; ADULT; AMMONIA BLOOD LEVEL; ARTICLE; CHILD; CLINICAL EVALUATION; CLINICAL FEATURE; EARLY DIAGNOSIS; FEMALE; HEMODIALYSIS; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NEWBORN; ONSET AGE; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRESCHOOL CHILD; PROGNOSIS; PROTEIN RESTRICTION; SURVIVAL RATE; UREA CYCLE DISORDER;

AGE OF ONSET; AMMONIA; FEMALE; HUMANS; JAPAN; MALE; ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; UREA; UREA CYCLE DISORDERS, INBORN;

EID: 84866735308     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9427-0     Document Type: Article

References (24)

1. Bachmann C (2003) Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr 162:410-416
2. Bachmann C (2005) Long-term outcome of urea cycle disorders. Acta Gastroenterol Belg 68(4):466-468
3. Batshaw ML, MacArthur RB, Tuchman M (2001) Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr 138 (1 Suppl):S46-S54
4. Braissant O, Henry H, Villard AM et al (2002) Ammonium-induced impairment of axonal growth is prevented through glial creatine. J Neurosci 22:9810-9820
5. Brusilow SW (1991) Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr Res 29(2):147-150
6. Brusilow SW, Valle DL, Batshaw M (1979) New pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet 2(8140):452-454
7. Feillet F, Leonard JV (1998) Alternative pathway therapy for urea cycle disorders. J Inher Metab Dis 21(Suppl 1):101-111
8. Kasahara M, Sakamoto S, Shigeta T et al (2010) Living-donor liver transplantation for carbamoyl phosphate synthetase 1 deficiency. Pediatr Transplant 14(8):1036-1040
9. Leonard JV (2001) The nutritional management of urea cycle disorders. J Pediatr 138(1 Suppl):S40-S44
10. Maestri N, Brusilow SW, Clissold DB, Bassett SS (1996) Long-term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med 335:855-859
11. Matsuda I, Tanase S (1997) The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency. Am J Med Genet 71:378-383
12. Matsuda I, Nagata N, Matsuura T et al (1991) Retrospective survey of urea cycle disorders: part 1. Clinical and laboratory observations of thirty-two Japanese male patients with ornithine transcarbamylase deficiency. Am J Med Genet 38:85-89
13. Morioka D, Kasahara M, Takada Y et al (2005) Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl 11(11):1332-1342
14. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits DE (1984) Neurological outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 310:1500-1505
15. Nagasaka H, Yorifuji T, Murayama K et al (2006) Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency. Eur J Pediatr 165(9):618-624
16. Nagata N, Matsuda I, Oyanagi K (1991a) Estimated frequency of urea cycle enzymopathies in Japan. Am J Med Genet 39:228-229
17. Nagata N, Matsuda I, Matsuura T et al (1991b) Retrospective survey of urea cycle disorders: part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies. Am J Med Genet 40:477-481
18. Nassogne MC, Héron B, Touati G, Rabier D, Saudubray JM (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28(3):407-414
19. Nicolaides P, Liebsch D, Dale N, Leonard J, Surtees R (2002) Neurological outcome of patients with ornithine carbamoyltransferase deficiency. Arch Dis Child 86(1):54-56
20. Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E (1999) Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 14(4):910-918
21. Summar M (2001) Current strategies for the management of neonatal urea cycle disorders. J Pediatr 138(1 Suppl):S30-39
22. Uchino T, Endo F, Matsuda I (1998) Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inher Metab Dis 21(Suppl 1):151-159
23. Uemoto S, Yabe S, Inomata Y et al (1997) Coexistence of a graft with the preserved native liver in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency. Transplantation 63 (7):1026-1028
24. Whitington PF, Alonso EM, Boyle JT et al (1998) Liver transplantation for the treatment of urea cycle disorders. J Inher Metab Dis 21 (Suppl 1):112-118